Research is needed to confirm these findings and optimize treatment strategies for this vulnerable population.
Retatrutide reduces thirst perception while GI symptoms can cause fluid loss
We believe in providing helpful information to our community, which is why we want patients to understand emerging options like the GLP-1 patch
Featured Clinical Research Sessions Featured Clinical Research I (Session 201) Saturday, March 28, Noon-1 PM CT, La Nouvelle B A Prospective Multicenter Registry to Define Coronary Vasomotor Disorders in Ischemia With Nonobstructive Coronary Arteries: Primary Results of Discover Inoca
Noom users on a GLP-1 lose 1.4x more weight than those on medication alone*, and in Nooms largest randomized controlled trial of its digital behavior program, members lost an average of 4.1% of their body weight and kept losing for a full year after the program ended , while a control group gained weight
MD: Supervision, Data curation, Conceptualization, Writing review & editing, Writing original draft
